---
title: 'Clinical Benefit of Cancer Drugs and Pricing'
subtitle: 'Coverage by the European Society of Medical Oncology (ESMO)'
summary: Coverage by the European Society of Medical Oncology (ESMO)
authors: 
- knvokinger
featured: true
date: "2019-09-27T00:00:00Z"
image:
  placement: 1
  caption: 'New studies question whether novel anti-cancer drugs are worth their extra cost'
  focal_point: ""
  preview_only: true
share: false
projects: []
---

Our recently published [study](https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30139-X/fulltext) on the association between the clinical benefit of recently approved cancer drugs and their average monthly treatment costs at launch was mentioned by [ESMO](https://www.esmo.org/newsroom/press-office/esmo-congress-anticancer-drugs-cost-marino-vokinger?hit=some). 
